# Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)

> **NCT00998634** · PHASE2 · COMPLETED · sponsor: **Federico II University** · enrollment: 20 (actual)

## Conditions studied

- SPINOCEREBELLAR ATAXIA 2

## Interventions

- **DRUG:** LITHIUM CARBONATE

## Key facts

- **NCT ID:** NCT00998634
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998634, "Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00998634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*